These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 33641830)

  • 1. Understanding the gaps in elimination of tuberculosis in India.
    Vashi K; Pathak YV; Patel J
    Indian J Tuberc; 2021 Jan; 68(1):114-118. PubMed ID: 33641830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Tuberculosis Cascade of Care in India's Public Sector: A Systematic Review and Meta-analysis.
    Subbaraman R; Nathavitharana RR; Satyanarayana S; Pai M; Thomas BE; Chadha VK; Rade K; Swaminathan S; Mayer KH
    PLoS Med; 2016 Oct; 13(10):e1002149. PubMed ID: 27780217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multidrug and extensively drug-resistant TB (M/XDR-TB): problems and solutions.
    Prasad R
    Indian J Tuberc; 2010 Oct; 57(4):180-91. PubMed ID: 21141336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tapping private health sector for public health program? Findings of a novel intervention to tackle TB in Mumbai, India.
    Shibu V; Daksha S; Rishabh C; Sunil K; Devesh G; Lal S; Jyoti S; Kiran R; Bhavin V; Amit K; Radha T; Sandeep B; Minnie K; Kaur GR; Vaishnavi J; Sudip M; Sameer K; Achutan NS; Sanjeev K; Puneet D
    Indian J Tuberc; 2020 Apr; 67(2):189-201. PubMed ID: 32553311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The making of a public health problem: multi-drug resistant tuberculosis in India.
    Engel NC
    Health Policy Plan; 2013 Jul; 28(4):375-85. PubMed ID: 22865835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Shifting the focus of tuberculosis research in India.
    Narayanan PR; Garg R; Santha T; Kumaran PP
    Tuberculosis (Edinb); 2003; 83(1-3):135-42. PubMed ID: 12758203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost effectiveness of decentralised care model for managing MDR-TB in India.
    John D; Chatterjee P; Murthy S; Bhat R; Musa BM
    Indian J Tuberc; 2018 Jul; 65(3):208-217. PubMed ID: 29933862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis of drug-resistant TB and provision of second-line TB treatment in India: some ethical considerations.
    Singh JA; Bhan A; Upshur R
    Indian J Med Ethics; 2013; 10(2):110-4. PubMed ID: 23697491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isoniazid mono-resistant tuberculosis: Time to take it seriously.
    Garg K; Saini V; Dhillon R; Agarwal P
    Indian J Tuberc; 2019 Apr; 66(2):247-252. PubMed ID: 31151492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of drug-resistant pulmonary tuberculosis in India: systematic review and meta-analysis.
    Goyal V; Kadam V; Narang P; Singh V
    BMC Public Health; 2017 Oct; 17(1):817. PubMed ID: 29041901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TB control in India--efforts, challenges and priorities.
    Sisodia RS; Jain DK; Agarwal SS; Gupta A
    J Indian Med Assoc; 2011 Dec; 109(12):921-4, 928. PubMed ID: 23469576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accelerating TB notification from the private health sector in Delhi, India.
    Kundu D; Chopra K; Khanna A; Babbar N; Padmini TJ
    Indian J Tuberc; 2016 Jan; 63(1):8-12. PubMed ID: 27235938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current and developing therapies for the treatment of multi drug resistant tuberculosis (MDR-TB) in India.
    Muniyandi M; Ramachandran R
    Expert Opin Pharmacother; 2017 Sep; 18(13):1301-1309. PubMed ID: 28786691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Homeopathic treatment in addition to standard care in multi drug resistant pulmonary tuberculosis: a randomized, double blind, placebo controlled clinical trial.
    Chand KS; Manchanda RK; Mittal R; Batra S; Banavaliker JN; De I
    Homeopathy; 2014 Apr; 103(2):97-107. PubMed ID: 24685414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a standardised multidrug-resistant/extensively drug-resistant tuberculosis assessment and monitoring tool.
    Migliori GB; Sotgiu G; Jaramillo E; Mirzayev F; Centis R; Colvin C; Richardson MD
    Int J Tuberc Lung Dis; 2009 Oct; 13(10):1305-8. PubMed ID: 19793438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical management of adults and children with multidrug-resistant and extensively drug-resistant tuberculosis.
    Dheda K; Chang KC; Guglielmetti L; Furin J; Schaaf HS; Chesov D; Esmail A; Lange C
    Clin Microbiol Infect; 2017 Mar; 23(3):131-140. PubMed ID: 27756712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis.
    Gandhi NR; Nunn P; Dheda K; Schaaf HS; Zignol M; van Soolingen D; Jensen P; Bayona J
    Lancet; 2010 May; 375(9728):1830-43. PubMed ID: 20488523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiological and behavioural correlates of drug-resistant tuberculosis in a Tertiary Care Centre, Delhi, India.
    Dzeyie KA; Basu S; Dikid T; Bhatnagar AK; Chauhan LS; Narain JP
    Indian J Tuberc; 2019 Jul; 66(3):331-336. PubMed ID: 31439176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controlling the drug-resistant tuberculosis epidemic in India: challenges and implications.
    Husain AA; Kupz A; Kashyap RS
    Epidemiol Health; 2021; 43():e2021022. PubMed ID: 33831293
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.